Market overview
consequences
Tandem Diabetes Care Inc. is a medical device company that develops products for people with insulin-dependent diabetes. The company has...
(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...